Cooke & Bieler LP’s Integra Lifesciences Hldgs C Position
Does Cooke & Bieler LP own Integra Lifesciences Hldgs C (IART)? Not currently — the last reported position was 3.51M shares worth $102M in Q2 2024; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$102M
Q2 2024
Shares
3.51M
% of Portfolio
+0.99%
Quarters Held
19
position exited
Position History IART
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q2 2024 | 3.51M | $102M | +0.99% |
| Q1 2024 | 3.13M | $111M | +1.02% |
| Q4 2023 | 2.83M | $123M | +1.09% |
| Q3 2023 | 2.71M | $104M | +1.01% |
| Q2 2023 | 2.74M | $113M | +1.05% |
| Q1 2023 | 2.66M | $153M | +1.49% |
| Q4 2022 | 2.73M | $153M | +1.50% |
| Q3 2022 | 2.73M | $116M | +1.24% |
| Q2 2022 | 2.49M | $135M | +1.30% |
| Q1 2022 | 2.53M | $163M | +1.43% |
| Q4 2021 | 2.38M | $159M | +1.37% |
| Q3 2021 | 2.38M | $163M | +1.48% |
| Q2 2021 | 2.75M | $188M | +1.73% |
| Q1 2021 | 2.70M | $187M | +1.81% |
| Q4 2020 | 2.71M | $176M | +1.92% |
| Q3 2020 | 2.47M | $116M | +1.55% |
| Q2 2020 | 2.30M | $108M | +1.48% |
| Q1 2020 | 2.23M | $100M | +1.60% |
| Q4 2019 | 1.76M | $102M | +1.10% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Cooke & Bieler LP’s full portfolio or all institutional holders of IART.